MDRPF News Alert Midas Gold Corp (MDRPF) 0.6080 09/21/2014 0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Midas Gold Corp (MDRPF) 0.6080 $MDRPF

Midas Gold Updates Mineral Resources for the Golden Meadows Project, Idaho
Marketwire - Wed Sep 10, 3:06PM CDT
Midas Gold Corp. (TSX: MAX)(OTCQX: MDRPF) today updated its mineral resource estimates for the Golden Meadows Project (the "Project" , located in the historic Stibnite-Yellow Pine mining district in Idaho. These updated estimates incorporate more than 45,000m of additional drilling completed since 2012 that was focused on converting mineral resources from the inferred to the indicated category within the limits of mining contemplated in the 2012 Preliminary Economic Analysis ("2012 PEA" . The 5.46 million oz of gold contained in the indicated mineral resources category represents an increase of 29% over previous estimates published in the 2012 PEA. The Project also contains approximately 1.07 million oz of gold in the inferred mineral resource category.

Midas Gold Provides Metallurgical Update on its Golden Meadows Au-Ag-Sb Project, Idaho
Marketwire - Wed Aug 20, 4:01PM CDT
Midas Gold Corp. (TSX: MAX) (OTCQX: MDRPF) today provided an update on its extensive independent metallurgical test program completed for the Golden Meadows Project, which is located in the historic Stibnite mining district of Idaho. Since the completion of the Preliminary Economic Assessment published in September 2012 (the "PEA" , Midas Gold's process and metallurgical consultants have focused on defining the metallurgical parameters for the Project for incorporation into a Preliminary Feasibility Study ("PFS" scheduled for completion later in 2014.

Teck Announces Subscription to Midas Gold Corp. Unit Placement
Marketwire - Tue Mar 04, 4:41PM CST
Teck Resources Limited (TSX: TCK.A and TCK.B, NYSE: TCK) ("Teck" announced today that it has subscribed for and acquired 1,277,621 units (the "Units" of Midas Gold Corp. (TSX:MAX / OTCQX:MDRPF) ("Midas Gold" , at a cost of $0.90 per Unit, as part of a non-brokered private placement (the "Placement" conducted by Midas Gold. Each Unit comprises one common share and one-half of one share-purchase warrant exercisable at $1.20 within 24 months of closing of the Placement. Combined with previous holdings, Teck holds 14,017,621 common shares of Midas Gold following the Placement. The shares, and shares that would be issued on exercise of the warrants, represent 10.3% of Midas Gold's outstanding common shares, calculated on a partially diluted basis assuming the exercise of the warrants held by Teck only.

Energizer Resources to Exhibit & Present at the 2014 Prospectors and Developers Association Investor Conference (PDAC)-Booth 2350
Marketwire - Tue Feb 25, 7:06AM CST
Energizer Resources Inc. (TSX: EGZ)(OTCQX: ENZR)(FRANKFURT: YE5) ("Energizer" or the "Company" announces that it will be exhibiting at the 2014 Prospectors & Developers Association of Canada (PDAC) International Trade Show & Investors Conference.

Vista Gold Completes Sale of 16 Million Shares of Midas Gold
Close-Up Media - Thu Feb 20, 12:20AM CST
Vista Gold Corp. announced that it has completed the previously announced sale of 16,000,000 common shares of Midas Gold Corp. for gross proceeds of Cdn$12.8 million.

Vista Gold Corp. Announces The Completion Of The Sale Of 16,000,000 Shares Of Midas Gold Corp.
PR Newswire - Fri Feb 14, 4:00PM CST
Vista Gold Corp. (TSX & NYSE MKT: VGZ) ("Vista" or the "Company" today announced that it has completed the previously announced sale of 16,000,000 common shares (the "Offered Midas Shares" of Midas Gold Corp. ("Midas" for gross proceeds of Cdn$12.8 million.

Midas Gold Supports Idaho Alpine Skier Erik Fisher for Sochi 2014 Olympic Winter Games
Marketwire - Fri Feb 07, 4:48PM CST
With the commencement of the Sochi 2014 Olympic Winter Games, Midas Gold Corp. (TSX: MAX)(OTCQX: MDRPF) is pleased to announce its sponsorship of downhill skier and Idaho native, Erik Fisher.

Vista Gold Corp. Announces Filing Of Notice And Confirmation Of Full Allocation Of Midas Gold Corp.
PR Newswire - Fri Feb 07, 6:00AM CST
Vista Gold Corp. (TSX & NYSE MKT: VGZ) ("Vista" or the "Company" today announced that, further to its February 5, 2014 press release, it has filed with Canadian securities regulatory authorities a notice of intention to distribute 16,000,000 common shares (the "Offered Midas Shares" of Midas Gold Corp. ("Midas" under section 2.8 of National Instrument 45-102 Resale of Securities. The sales of the Offered Midas Shares will not be completed until the satisfaction of a number of customary closing conditions. Closing of the Offered Midas Shares is expected to occur on or about February 14, 2014, being the first day the Offered Midas Shares may be sold.

Midas Gold Reports That Vista Gold has Agreed to Reduce Its Shareholdings to 12.4%
Marketwire - Thu Feb 06, 6:48AM CST
Midas Gold Corp. (TSX: MAX)(OTCQX: MDRPF) reports that it has been notified by Vista Gold Corp. ("Vista" that Vista has entered into an agreement to sell 16.0 million shares of Midas Gold Corp. ("Midas Gold" held by Vista and/or its subsidiaries to certain arm's-length parties at a fixed price of C$0.80 per share. Once completed, this transaction will reduce Vista's shareholdings in Midas Gold from 31,802,615 shares (representing 24.94% of Midas Gold's currently issued shares) to 15,802,615 shares (representing 12.39% of Midas Gold's issued shares). Midas Gold understands that the entire 16.0 million shares have subsequently been placed. As a condition of the sale of 16.0 million shares, Vista Gold has agreed not to sell any of its remaining shares in Midas Gold for a period of 12 months from the closing of the share sale transaction.

Vista Gold Corp. Enters Into an Agency Agreement for the Sale of 16,000,000 Shares of Midas Gold Corp.
Marketwire - Thu Feb 06, 12:31AM CST
Vista Gold Corp. (TSX: VGZ)(NYSE MKT: VGZ)(NYSE Amex: VGZ) ("Vista" or the "Company" today announced that it intends to file with Canadian securities regulatory authorities a notice of intention to sell up to 16,000,000 common shares (the "Offered Midas Shares" of Midas Gold Corp. ("Midas" under section 2.8 of National Instrument 45-102 Resale of Securities. Vista may commence selling the Offered Midas Shares on or about February 14, 2014.

Midas Gold Reports Results of Final 24 Holes from 2013 Drilling at Golden Meadows
Marketwire - Mon Jan 27, 7:02AM CST
Midas Gold Corp. (TSX: MAX)(OTCQX: MDRPF) today reported results from the final 24 holes completed during its 2013 in-fill and mineral resource definition core drilling program at its Golden Meadows Project, in the Stibnite-Yellow Pine Mining District, Idaho. A total of 11,655m of drilling, in 123 holes of various types, was completed during the 2013 program.

2013 Report on the US Biochip Products and Services Market - Trends and Forecast to 2018
M2 - Fri Jan 17, 5:38AM CST
Research and Markets (http://www.researchandmarkets.com/research/jnxzz9/biochip_products) has announced the addition of the "2013 Report on the US Biochip Products and Services Market - Trends and Forecast to 2018" report to their offering. The U.S. biochip product market held majority share of the total biochip market in 2011, at over 70%. However, the U.S. biochip services market will grow faster than the products market, due to increased opportunities of maintenance and technical support of microarray devices owing to growth in their numbers and obsolescence of older machines. The growth of this segment will also be spurred by the introduction of biochip consulting and subscription programs directed towards building long term relationships with customers. Biochip services consist of contract research, consulting and technical support agreements. These also comprise of subscription programs that provide end-users with access to proprietary technologies, systems and processes. These services are directed towards building long term relationships with customers. In the U.S. biochip products market, the microarray market is identified as the most attractive segment owing to the following factors: - Large number of applications of microarrays, for example, gene expression profiling, comparative genomic hybridization, geneID, cancer and genetic disorder treatment, personalized medicine, drug discovery and many others - The U.S. governments promotional initiative towards research of cancer treatment through genetics (e.g. The Human Genome Project, by the Department of Energy, U.S.) will strengthen the demand for microarrays in the field of cancer treatment - The rapid growth in the personalized medicine market in the U.S. will further drive the demand for microarrays Key Topics Covered: 1 Preface 2 Executive Summary 3 Market Overview 4 U.S. Biochip Market, by Segments 5 U.S. Biochip Products Market, by Type 6 The U.S. Biochip Products and Services Market, by Application 7 Competitive Landscape 8 Company Profiles Companies Mentioned: - Abbott Laboratories - Affymetrix Inc. - Agilent Technologies - Beckman Coulter, Inc. - Illumina Incorporated - Life Technologies Corporation - GE Healthcare - Roche For more information visit http://www.researchandmarkets.com/research/jn...p_products

eXelate Expands Global Data Coverage Through Strategic Partnership With French Company SirData
Marketwire - Thu Dec 19, 11:00AM CST
eXelate, the leading smart data and analytics engine powering smarter digital marketing decisions, today announced the forging of an alliance with a leading French audience targeting data provider, SirData. As a result, the eXelate eXchange will initially ingest 6M French audience targeting intent data users across 65 segments, such as banking, phone subscription, camera, bargain shoppers, books and small household appliances. This will provide advertisers, agencies, and trading desks with robust, highly accurate consumer marketing and online shopping behavior data in order to drive improved campaign effectiveness. SirData will utilize eXelate's data software platform to onboard, distribute, and monetize their consumer data assets.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 188

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 169

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharma Equity Group's Journey Through H1 2025 Financials

Updated Category News Views 138

Pharma Equity Group's Interim Report for First Half of 2025 Key Highlights of H1 2025 Recently, Pharma Equity Group A/S underwent a thorough review by its Board of Directors and Executive Board, affirming their progress and strategies during the first half of 2025. Strategic Developments In a significant strategic shift, Pharma Equity Group has launched a new growth...

Continue Reading
Euro Manganese Welcomes New Director to Enhance Leadership Team

Updated Category News Views 110

Euro Manganese Inc. took a bold step back in 2024 when it brought on board Ms. Ludivine Wouters as a non-executive Director. This move was no ordinary appointment; it marked a significant shift in the company’s strategy as it aimed to solidify its presence in the battery materials sector, especially crucial for the electric vehicle (EV) industry. Strategic Shift: New...

Continue Reading
Gneuton Innovations: Revolutionizing Water Sustainability in AI

Updated Category News Views 333

Gneuton Innovations in AI Data Centers Gneuton, a groundbreaking clean technology company, is making waves in the field of regenerative AI infrastructure. The company has recently introduced a unique deployable water purification system that operates within gas turbine-powered AI data centers. This innovative system utilizes a patented thermal distillation technique,...

Continue Reading
Transamerica Reinforces Leadership for Retirement Expansion

Updated Category News Views 10

Transamerica's Next Phase: Leadership Moves in Retirement Transamerica just pulled a move that’s both bold and calculated. They’ve beefed up their retirement distribution squad with Danny Kling and Kevin Murphy stepping into the spotlight. These guys are bringing heaps of experience and a fresh jolt of energy to keep the momentum going. No doubt this is Transamerica...

Continue Reading
Unity Bancorp Drives Forward with Exciting Dividend Announcement

Updated Category News Views 129

Unity Bancorp Declares Cash Dividend for Shareholders Unity Bancorp, Inc. (NASDAQ: UNTY), the parent company of Unity Bank, has made an exciting announcement regarding its commitment to rewarding shareholders. The company's Board of Directors has declared a cash dividend amounting to $0.15 per common share. This dividend, representing a positive sign for shareholders,...

Continue Reading